Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Cell Stem Cell. 2013 Jan 3;12(1):114-26. doi: 10.1016/j.stem.2012.11.002.
Adoptive immunotherapy with functional T cells is potentially an effective therapeutic strategy for combating many types of cancer and viral infection. However, exhaustion of antigen-specific T cells represents a major challenge to this type of approach. In an effort to overcome this problem, we reprogrammed clonally expanded antigen-specific CD8(+) T cells from an HIV-1-infected patient to pluripotency. The T cell-derived induced pluripotent stem cells were then redifferentiated into CD8(+) T cells that had a high proliferative capacity and elongated telomeres. These "rejuvenated" cells possessed antigen-specific killing activity and exhibited T cell receptor gene-rearrangement patterns identical to those of the original T cell clone from the patient. We also found that this method can be effective for generating specific T cells for other pathology-associated antigens. Thus, this type of approach may have broad applications in the field of adoptive immunotherapy.
过继免疫疗法利用功能 T 细胞,是一种对抗多种癌症和病毒感染的有效治疗策略。然而,抗原特异性 T 细胞的耗竭是这种方法的主要挑战。为了克服这个问题,我们将一名 HIV-1 感染者的克隆扩增的抗原特异性 CD8(+)T 细胞重编程为多能性。然后,将 T 细胞衍生的诱导多能干细胞再分化为具有高增殖能力和延长端粒的 CD8(+)T 细胞。这些“年轻化”的细胞具有抗原特异性杀伤活性,并表现出与患者原始 T 细胞克隆相同的 T 细胞受体基因重排模式。我们还发现,这种方法可以有效地为其他与病理相关的抗原生成特异性 T 细胞。因此,这种方法可能在过继免疫疗法领域有广泛的应用。